Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.

Andrikopoulos P, Kieswich J, Pacheco S, Nadarajah L, Harwood SM, O'Riordan CE, Thiemermann C, Yaqoob MM.

J Am Soc Nephrol. 2019 Jan;30(1):33-49. doi: 10.1681/ASN.2018020209. Epub 2018 Dec 10.

PMID:
30530834
2.

Ischemic conditioning in solid organ transplantation: is it worth giving your right arm for?

Nadarajah L, Yaqoob MM, McCafferty K.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):467-476. doi: 10.1097/MNH.0000000000000367. Review.

PMID:
28877040
3.

Major bleeding in hemodialysis patients using unfractionated or low molecular weight heparin: a single-center study.

Nadarajah L, Fan S, Forbes S, Ashman N.

Clin Nephrol. 2015 Nov;84(5):274-9. doi: 10.5414/CN108624.

PMID:
26365216
4.

A novel claudin-16 mutation, severe bone disease, and nephrocalcinosis.

Nadarajah L, Khosravi M, Dumitriu S, Klootwijk E, Kleta R, Yaqoob MM, Walsh SB.

Lancet. 2014 Jan 4;383(9911):98. doi: 10.1016/S0140-6736(13)62673-2. No abstract available.

PMID:
24388313
5.

Literature review of passenger lymphocyte syndrome following renal transplantation and two case reports.

Nadarajah L, Ashman N, Thuraisingham R, Barber C, Allard S, Green L.

Am J Transplant. 2013 Jun;13(6):1594-600. doi: 10.1111/ajt.12219. Epub 2013 Apr 25. Review.

Supplemental Content

Loading ...
Support Center